TumorXpert™ — India's First Patented Neuro-Symbolic AI Platform for Multi-Organ Cancer Diagnostics
" At the heart of our Innovation is TumorXpert, a (patented) neuro-symbolic AI platform that combines deep learning, symbolic reasoning, and explainable AI to deliver highly accurate, reliable, and transparent cancer detection across multiple tumor types."
– NeuraXion Labs Vision
– NeuraXion Labs Vision
How our Innovation "TumorXpert" solve this Market problem
TumorXpert – AI-Powered Diagnostic Platform
A patented neuro-symbolic AI system that combines deep learning, symbolic reasoning, and explainable AI to deliver highly accurate, reliable, and transparent cancer diagnostics across multiple tumor types.
Explainable & Clinically Aligned Foundation Model for Oncology
Large foundation model for cancer diagnostics, adaptable for brain, lung, breast, skin, gastrointestinal, throat, and other cancers.
Tele Radiologist
First AI-assisted radiology platform powered by TumorXpert and AI, analyzes the medical images, creates a diagnostic report and sends it back to the referring doctors within minutes to hours at 1/3 cost. It can act as BPO service offering for every Hospital/ Cancer Diagnostic center.
Virtual Tumor Board (Direct to Patients) Platform
First structured D2P platform, provide Patients and Hospitals in Tier 2/ tier 3 cities a secured video consultation between oncologists, radiologists. It create impact in democratizes expert opinion for complex cases across geographies.
What we Offer ?
“AI for All,” focusing on indigenous, affordable, and inclusive solutions to bridge accessibility gaps, particularly in diagnostics and predictive care.
TumorXpert – AI-Powered Diagnostic Ecosystem
A patented neuro-symbolic AI platform that combines deep learning, symbolic reasoning, and explainable AI to deliver highly accurate, reliable, and transparent cancer diagnostics across multiple tumor types.
Specialized Oncology Foundation Model
Follow large foundation model for oncology diagnostics, adaptable for brain, lung, breast, skin, gastrointestinal, throat, and other cancers, creating a unified and scalable AI layer for healthcare systems.
Tele Radiologist (Explainable & Clinically Aligned AI Diagnosis)
Built-in XAI frameworks provide visual and feature-level explanations for predictions, ensuring clinical trust, regulatory readiness, and adoption.
Virtual Tumor Board (Direct to Patients) Platform
Structured platform, provide Patients and Hospitals in Tier 2/ tier 3 cities a secured video consultation between oncologists, radiologists. Rapid adoption across government hospitals, rural health centers, and global facilities, with seamless integration into radiology IT systems (PACS/RIS).
TumorXpert™ — AI-Powered Cancer Diagnostic Ecosystem
A patented neuro-symbolic AI platform combining Deep Learning, Symbolic Reasoning, and Explainable AI for highly accurate, reliable, and transparent cancer detection across multiple tumor types.
PhD Research
"NeuroTumorXpert: A Transfer Deep Learning Model for Detection and Multi-Classification of Brain Tumor via Magnetic Resonance Imaging"
PhD Research
NeuroTumorXpert: A Transfer Deep Learning Model for Detection and Multi-Classification of Brain Tumor via Magnetic Resonance Imaging"
Published in Journal of Information Systems Engineering and Management
Patent
Kathuria, “Method for classifying brain tumor from a plurality of medical images,” Patent No – 202511054456, filed on June 2025.
Patent
Kathuria, “Method for classifying brain tumor from a plurality of medical images,” Patent No – 202511054456, filed on June 2025.
APPROVED By India Patent Office
TumorXpert: A Transfer Deep Learning Model for Detection and Multi-Classification of Brain Tumor via MRI –
NeuroTumorXpert: A Transfer Deep Learning Model for Detection and Multi-Classification of Brain Tumor via MRI — Journal of Information Systems Engineering and Management
Enhanced MRI-Based Brain Tumor Classification through Transfer Learning Techniques — International Journal of Sustainable Building Technology and Urban Development
CNN-based Framework for Brain Tumor Classification and Segmentation using MR Images — Journal of Visualized Experiments
A Comprehensive Review on Brain Tumor Detection using Artificial Intelligence — 10th International Conference on Advanced Computing and Communication Systems (ICACCS)
Enhancing Brain Tumor Detection with ResNet101: A Deep Learning Approach — International Conference on Data Mining and Information Security (ICDMIS)
TumorXpert™ — Patented Neuro-Symbolic Architecture: Combining the Power of Accuracy (Deep Learning) with Trust (Symbolic AI + Explainable AI)
The biggest challenge in clinical AI diagnosis is the sensitivity–specificity trade-off. Tuning a model to increase sensitivity (true positive rate) leads to more false positives (lower specificity), and vice versa. Symbolic AI focuses on explicit knowledge representation and logical reasoning, rather than statistical patterns — overcoming this fundamental limitation.
Hence NeuraXion Labs, developed revolutionary approach NeuraXion Labs developed TumorXpert™ — a patented neuro-symbolic AI system that combines deep learning (neural networks) with symbolic AI (knowledge graphs and logic). This hybrid approach delivers highly accurate, reliable, and transparent cancer diagnostics. Symbolic constraints rule out biologically or clinically implausible predictions, boosting both sensitivity and specificity simultaneously..
Value Proposition and Impact
- Tele Radiologist (First Mover): First AI-assisted radiology platform powered by TumorXpert. Analyzes medical images, creates a diagnostic report, and sends it back to referring doctors within minutes — at 1/3 the cost. Can act as a BPO service for every hospital and cancer diagnostic center.
- Clinical Impact: TumorXpert’s high diagnostic precision enables faster, more targeted interventions, increasing survival rates and reducing long-term neurological impairment in patients.
- Operational Efficiency: Automated triaging reduces the workload on specialized radiologists, empowering primary care and district health centers to handle advanced diagnosis, thus mitigating staff shortages and urban-rural disparities.
- Economic Value: Early, accurate diagnosis reduces repeat imaging, misdiagnosis costs, and late-stage treatment expenses.
- Wider Coverage and full-blown diagnosis solution for all type of Tumor/ Cancer: Foundation model will be leverage and enable similar diagnosis for all other type of cancers – skin/ Lungs/ Breast / stomach/ throat etc
- Scalability & Accessibility: Secured cloud-ready, hardware-light deployment ensures rapid adoption across government hospitals, rural health centers, and global facilities with minimal IT investment. This allows rapid deployment across healthcare facilities with minimal IT investment, including public hospitals and rural clinics.
- Virtual Tumor Board — Direct to Patients (D2P): First structured platform providing Tier 2/Tier 3 city patients and hospitals secured video consultation between oncologists, radiologists, and pathologists — democratizing expert cancer opinion at 1/3 cost.
Scientific & Technological Edge
- Patented Neuro-Symbolic Architecture: Combines Deep Learning + Symbolic AI + Explainable AI — delivering 99.9% clinical accuracy, outperforming global AI imaging solutions.
- First Oncology Large Foundation Model in India: Large-scale AI foundation model for multi-organ cancer diagnostics — Brain, Lung, Breast, Skin, GI, Throat.
- Explainability & Regulatory Readiness: Built-in XAI frameworks provide intuitive visual explanations — ensuring trust, auditability, and compliance for high-stakes medical workflows.
- Validated Innovation: Clinical accuracy tested at 99.9%. Published and cited in multiple international conferences and high-impact journals. India Patent filed and approved, June 2025.
- Wider Research: TumorXpert benchmarked against state-of-the-art research papers and AI models from 2000 to 2025 — outperforms all models tested.
- Proven Outcomes: Peer-reviewed publications support TumorXpert’s superiority over leading global AI solutions for medical imaging.
See it in Action
TumorXpert — a patented neuro-symbolic AI platform combining deep learning, symbolic reasoning, and explainable AI. Clinical accuracy tested at 99.9%, outperforming global AI solutions. Ideation, innovation, and pilot development finished. Testing is in progress for highly accurate, explainable, and reliable brain tumor/cancer detection from MRI. Extending architecture to Lung Cancer and Breast Cancer.
Validated on +2,000 real cases from LIDC & Israeli hospitals databases and in the Assuta clinical study.
TumorXpert — fast, explainable AI for multimodal brain-tumor detection, molecular prediction, and intraoperative decision support.
TumorXpert offers a suite of powerful features designed to enhance diagnostic accuracy and efficiency.
TumorXpert — AI-Powered Diagnostic Ecosystem
A patented neuro-symbolic AI platform combining deep learning, symbolic reasoning, and explainable AI for highly accurate, reliable, and transparent cancer diagnostics across multiple tumor types.
First Tele Radiologist (World First)
AI-assisted radiology platform analyzes medical images, creates a diagnostic report, and sends it back to referring doctors within minutes — at 1/3 the cost. Acts as a BPO service for every hospital and cancer diagnostic center.
Virtual Tumor Board — Direct to Patients (D2P)
First structured D2P platform providing patients and hospitals in Tier 2/Tier 3 cities secured video consultation between oncologists, radiologists, and pathologists — democratizing expert cancer opinion for complex cases across geographies.
